Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis

NCT07055724 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

AL Amyloidosis

Interventions

BIOLOGICAL: Eque-cel CAR-T Therapy

Sponsor

Nanjing IASO Biotechnology Co., Ltd.